MAGE3/Survivin/CEA expressing CTCs were predictors for response of cryosurgery20, while pERK+/pAkt− or PD-L1 + CTCs were respectively correlated with therapeutic response to sorafenib or anti-PD-1 therapy in HCC patients21,22. This evidence concerns the gene EIF2AK3 and hepatocellular carcinoma.